Wealth Quarterback LLC Vertex Pharmaceuticals Inc Transaction History

Wealth Quarterback LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$234.96 - $292.55 $23,261 - $28,962	-99 Closed	0 $0
Q2 2021 Aug 11, 2021	BUY	$187.49 - $221.1 $18,561 - $21,888	99 New	99 $20,000
Q2 2020 Aug 17, 2020	SELL	$225.48 - $295.8 $21,195 - $27,805	-94 Closed	0 $0
Q1 2020 May 14, 2020	SELL	$199.77 - $247.81 $2.43 Million - $3.02 Million	-12,189 Reduced 99.23%	94 $22,000
Q4 2019 Feb 27, 2020	BUY	$166.71 - $223.91 $2.05 Million - $2.75 Million	12,283 New	12,283 $2.69 Million

1,723

222M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $116B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Wealth Quarterback LLC, based on Form 13F filings with the SEC.

Stay updated on Wealth Quarterback LLC with notifications on news.